Study on endogenous inhibitors against PD-L1: cAMP as a potential candidate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Study on endogenous inhibitors against PD-L1: cAMP as a potential candidate

Published:2023-03 Issue: Volume:230 Page:123266
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Huang Qiuyang,Zang Xiaoling,Zhang Zhiwei,Yu Hang,Ding Baoyan,Li Zhuangzhuang,Cheng Simin,Zhang Xin,Ali Mustafa R.K.,Qiu Xue,Lv Zhihua

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference80 articles.

1. Development of the inhibitors that target the PD-1/PD-L1 interaction-a brief look at Progress on small molecules,peptides and macrocycles;Guzik;Molecules,2019

2. PD-1-targeted discovery of peptide inhibitors by virtual screening, molecular dynamics simulation, and surface plasmon resonance;Wang;Molecules,2019

3. Avelumab: first global approval;Kim;Drugs,2017

4. PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer;Cercek;N. Engl. J. Med.,2022

5. Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1);Zak;Oncotarget,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. α-Glucosidase inhibitors derived from black soybean and their inhibitory mechanisms;LWT;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP